Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-11-23 19:38:40 UTC |
---|
Updated at | 2021-08-12 19:51:57 UTC |
---|
NP-MRD ID | NP0002717 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | N-Carbamyl-L-glutamic acid |
---|
Provided By | BMRB |
---|
Description | Carglumic acid, also known as carbaglu or acide carglumique, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Carglumic acid is a drug which is used for the treatment of acute and chronic hyperammonaemia in patients with n-acetylglutamate synthase (nags) deficiency. This enzyme is an important component of the urea cycle to prevent build up of neurotoxic ammonium in the blood. . Carglumic acid is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. N-Carbamyl-L-glutamic acid was first documented in 2002 (PMID: 12447942). Based on a literature review a small amount of articles have been published on Carglumic acid (PMID: 15480384) (PMID: 20410539) (PMID: 21941437). |
---|
Structure | NC(=O)N[C@@H](CCC(O)=O)C(O)=O InChI=1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(2S)-2-(Carbamoylamino)pentanedioic acid | ChEBI | Acide carglumique | ChEBI | Acido carglumico | ChEBI | Acidum carglumicum | ChEBI | Carbaglu | ChEBI | Carbamino-L-glutamic acid | ChEBI | Carbamylglutamic acid | ChEBI | L-N-Carbamoylglutamic acid | ChEBI | Ureidoglutaric acid | ChEBI | (2S)-2-(Carbamoylamino)pentanedioate | Generator | Carbamino-L-glutamate | Generator | Carbamylglutamate | Generator | L-N-Carbamoylglutamate | Generator | Ureidoglutarate | Generator | Carglumate | Generator | (S)-2-Ureidopentanedioic acid | HMDB | N-Carbamoyl-L-glutamic acid | HMDB | N-Carbamyl-L-glutamate | HMDB | N-Carbamylglutamate | HMDB | N-Carbamoyl-L-glutamate | MeSH, HMDB | N-Carbamoylglutamate | MeSH, HMDB |
|
---|
Chemical Formula | C6H10N2O5 |
---|
Average Mass | 190.1540 Da |
---|
Monoisotopic Mass | 190.05897 Da |
---|
IUPAC Name | (2S)-2-(carbamoylamino)pentanedioic acid |
---|
Traditional Name | carglumic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC(=O)N[C@@H](CCC(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1 |
---|
InChI Key | LCQLHJZYVOQKHU-VKHMYHEASA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Glutamic acid and derivatives |
---|
Alternative Parents | Not Available |
---|
Substituents | Not Available |
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Elpeleg O, Shaag A, Ben-Shalom E, Schmid T, Bachmann C: N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy. Ann Neurol. 2002 Dec;52(6):845-9. doi: 10.1002/ana.10406. [PubMed:12447942 ]
- Caldovic L, Morizono H, Daikhin Y, Nissim I, McCarter RJ, Yudkoff M, Tuchman M: Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate. J Pediatr. 2004 Oct;145(4):552-4. doi: 10.1016/j.jpeds.2004.06.047. [PubMed:15480384 ]
- Thompson CA: Carglumic acid approved to treat genetic hyperammonemia. Am J Health Syst Pharm. 2010 May 1;67(9):690. doi: 10.2146/news100031. [PubMed:20410539 ]
- Haberle J: Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency. Ther Clin Risk Manag. 2011;7:327-32. doi: 10.2147/TCRM.S12703. Epub 2011 Aug 2. [PubMed:21941437 ]
|
---|